European shares fell on Friday, dragged down by disappointing earnings, concerns about the impact of U.S. President-elect Donald Trump's policies, and a jump in Treasury yields. Investors were also ...
EMA human medicine committee recommends approval of Sanofi’s Sarclisa to treat transplant-ineligible newly diagnosed multiple myeloma: Paris Saturday, November 16, 2024, 09:00 H ...
FRANKFURT: European shares slipped on Friday, weighed down by disappointing earnings, concerns about the impact of ...
Kennedy has been criticized for making false medical claims. He has also vowed to purge the U.S. Food and Drug Administration ...
Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore ...